Bioscience Biotechnology Research Communications

An Open Access International Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Naheda Alshammari1, Magda Aly1,2* and Nabeela  Al-Abdullah3,4

1Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

2Botany and Microbiology Department, Faculty of Science, Kafrelsheikh University, Egypt

3Infection Control and Environmental Health Unit, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia

4Department of Public Health, Faculty of Nursing, King Abdulaziz University, Jeddah, Saudi Arabia

Corresponding author email: magdammali@hotmail.com

Article Publishing History

Received: 25/11/2020

Accepted After Revision: 19/03/2021

ABSTRACT:

Antibiotic resistance bacteria developed abilities to resist antibiotics designed to kill them and mainly spread in hospitals compared to community. One of the biggest risks is getting an antibiotic-resistant infection from healthcare facility such as a hospital where patients are exposed to antibiotics. Moreover, resistant bacteria are more difficult to treat speciallyin immunocompromised patients Prevention of the spread of resistant bacteria can be done by recommended practices for identifying these bacteria, cleaning hands, wearing gowns and gloves, and cleaning medical equipment in addition to patient care areas.

This article reviews the relevant knowledge of the epidemiology and molecular characteristics of resistant bacteria in Saudi Arabia. Multidrug-resistant Gram-negative (MDR-GN) bacteria are serious threats to public health especially extended-spectrum β-lactamase Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa which increased morbidity and mortality in hospitals. These pathogens raise serious concern in both hospitals and community settings and have become endemic in many tertiary hospitals and health care units worldwide. Moreover, the emergence and rapid spread of MDR-GN bacteria in hospitals have a significant impact on treatment outcomes and pose challenges to health care systems and medical care cost and effectiveness.

KEYWORDS:

Antibiotics, Resistance,   K. Pneumoniae, A. Baumannii, P. Aeruginosa

Download this article as:

Copy the following to cite this article:

Alshammari N, Aly M, Al-Abdullah N. Prevalence of Multidrug-Resistant Gram-Negative Bacteria in Saudi Arabia: Meta Review. Biosc.Biotech.Res.Comm. 2021;14(1).


Copy the following to cite this URL:

Alshammari N, Aly M, Al-Abdullah N. Prevalence of Multidrug-Resistant Gram-Negative Bacteria in Saudi Arabia: Meta Review. Biosc.Biotech.Res.Comm. 2021;14(1). Available from: <a href=”https://bit.ly/3c214zE”>https://bit.ly/3c214zE</a>


INTRODUCTION

Multidrug-resistant Gram-negative bacteria (MDR-GN) are among the most serious threat to public health, due to their resistance to nearly all available antibiotics (Ventola, 2015; Exner et al., 2017; Alagna et al., 2020; Nijsingh et al., 2020). The Infectious Diseases Society of America (IDSA) has identified four Gram-negative pathogens of particular importance, extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (E. coli), Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa (Bassetti et al., 2016; Fodor et al., 2020; Morris and Cerceo, 2020).

Also, treatment options for these Gram-negative pathogens are rapidly declining, which leads to significant increases in morbidity and mortality (Karaiskos et al., 2019). These pathogens raise serious concern in both hospitals and community settings and have become endemic in many tertiary hospitals and health care units worldwide (Peleg and Hooper, 2010; Gray and Mahida, 2016). Moreover, the emergence and rapid spread of (MDR-GN) in hospitals pose challenges to health care systems, medical care cost and effectiveness (Santajit and Indrawattana, 2016; Serra-Burriel et al., 2020).

Multidrug-resistant Gram-negative bacteria have been detected in Saudi Arabia since the 1990s. Many published studies from Saudi Arabia have focused on the molecular epidemiology of these pathogens (Zowawi et al., 2014; Zowawi, 2016). Several studies from different regions in Saudi Arabia have reported increasing carbapenem resistance among MDR-GN bacteria (Yezli et al., 2014, Faidah et al., 2017).  Carbapenem-resistant Acinetobacter baumannii is the most common pathogens associated with nosocomial infection followed by Pseudomonas aeruginosa. Recently, the rate of carbapenem-resistant Enterobacteriaceae has been increasing (Alotaibi et al., 2017).

The four Gram-negative pathogens identified by IDSA are the most frequent in KSA hospitals (Zowawi et al., 2014, Zowawi, 2016, Khan et al., 2018). This article reviews the relevant knowledge of the epidemiology and molecular characteristics of the four MDR-GN pathogens, extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, in Saudi Arabia.

Multidrug-resistant gram-negative bacteria:  A systematic search was conducted in specific online databases, including PubMed, Google Scholar, and Science Direct. The search strategy was focused on publications from the 2015 to 2020. Therefore, we used English key terms related to Multidrug-resistant gram-negative bacteria, molecular epidemiology, and antibiotic resistance. Different forms of the main terms were included in our search for example, MGN- extended Spectrum β Lactamase (ESBL), carbapenem resistant Enterobacteriaceae (CRE).

The names of the four MDR-GN pathogens: E. coli, K. pneumoniae, P. aeruginosa, A. baumannii were also included. Since we are targeting studies about the Multidrug-resistant gram-negative bacteria in Saudi Arabia, the official name of Saudi Arabia, “Kingdom of Saudi Arabia” or “KSA”, was included in the list of the key searching terms.  A total of 80 studies were selected for this review within the time window of the five-year. Most of these studies (23%) were published in 2019. The retrieved results for this review were classified based on the four MDR-GN pathogens. Each subsection starts with a brief background of MDR-GN pathogens under the study.

The reported findings of the antimicrobial resistance rates and the resistant genes presented in each MDR-GN bacteria from all the studies collected in this review were summered. The retrieved results for this review were classified based on the four MDR-GN pathogens. Each subsection starts with a brief background of  MDR-GN pathogens under the study. The reported findings of the antimicrobial resistance rates and the resistant genes presented in each MDR-GN bacteria from all the studies collected in this review were summered.

Multidrug-resistant Klebsiella pneumoniae: Over the years, K. pneumoniae has become an important opportunistic pathogen, that belong to the Enterobacteriaceae family, and a member of ESKAPE pathogens. Three to eight percent of hospital-acquired bacterial infections are related to K. pneumonia (Ashurst and Dawson, 2019).

It is responsible for several diseases such as urinary tract infections, cystitis, pneumoniae, surgical wound infections and septicemia. K. pneumoniae demonstrated a significant resistance to antimicrobial groups such as β-lactam antibiotics, Cephalosporin’s, aminoglycosides, fluoroquinolones, and Carbapenems (Dsouza et al., 2017). The emergence of K. pneumoniae strains resistant to broad-spectrum antimicrobial agents are a serious threats to the public health due to the limited treatment options (Navon-Venezia et al., 2017).

Numerous studies reported the prevalence of MDR-K. pneumoniae in Saudi hospital settings. In Riyadh Medical City, out of 227 of Enterobacteriaceae isolates 60% were MDR pathogens. K. pneumoniae accounted for 33% of infections. 51.4% of the total isolates were ESBL producers and10.1% were Carbapenemase-producing Enterobacteriaceae (Alkofide et al., 2020). At King Fahad Medical City at Riyadh, the most identified isolates were K. pneumoniae (47.4%) and E. coli (31.6%) (Alzomor et al., 2019).

Another study by Bandy and Almaeen, (2020) was conducted in two specialist hospitals in Aljouf region, 222 non-duplicates Blood stream infections (BSI) samples from hospitalized patients, 62.2% were caused by gram-negative bacteria. K. pneumoniae was the most frequent (28.4%) pathogen. Moreover, 46% of K. pneumoniae isolates were carbapenemase producers and 52.2% of E. coli isolates were ESBL producers.

The prevalence of Carbapenem-resistant   K. pneumoniae was 92.8%, followed by E. coli in 6.7%, and Enterobacter in 0.6%. In KAUH the percentage of CRE increased from 8% in 2017 to 13% in 2018. While in KAMC, the percentage was much higher throughout this study 43.2% in 2018 and 39% in 2019 (Taha et al.,2020).

Another study performed by Ghanem et al.(2017) at King Fahd Hospital in Madinah, showed that K. pneumoniae species 100% resistance to Ampicillin. Among 15708 K. pneumonia isolates collected from 1149 patients at King Fahad Hospital in Medina, resistance rate was  38.4%  for imipenem and 46.1% for meropenem, as well as high resistance rates for 40.7% and 53.3% for colistin and tigecycline, respectively (Al-Zalabani et al.,2020).

In Abha, a study conducted that K. pneumoniae isolates were highly resistant against ciprofloxacin, piperacillin-tazobactam, ceftazidime, cefepime, amikacin, and gentamicin (Al-Zahrani and Alasiri, 2018). At Aseer Central Hospital, K. pneumoniae had high rates of resistance to ampicillin, extended-spectrum β-lactamases-sulbactam (ESBL-SCM), piperacillin (100%), and to a lesser extent ceftazidime (92.5%), minocycline (80.2%), ceftriaxone (80.1%), and tetracycline (80%) (Al Bshabshe et al., 2020).

K. pneumoniae ESBL-producing isolates (n-23) were collected from various body sites of patients at King Khalid University Hospital, Riyadh (Azim et al., 2019).  Also, K. pneumoniae  was one the most common UTI-causative and showed the highest resistance to ampicillin (97%) sulfamethoxazole/ trimethoprim (35%) and cefuroxime (30%) (Balkhi et al., 2018).

Several studies from Saudi Arabia have reported the prevalence of antimicrobial resistance genes and detected multiple resistance genes among K. pneumoniae isolates, such as CTX-M, TEM, BES and SHV genes that are associated with extended spectrum β-lactamases. NDM-1, OXA-48, SME, IMI, NMC, GES, and KPC are the predominant mechanisms of carbapenem resistance (Azim et al., 2019). Table 1 describes the molecular characteristics of MDR K. pneumoniae isolates, the regional distribution and number of cases from several studies from Saudi Arabia hospitals.

Table 1. Types of β-lactamase and carbapenems resistant genes carried by K. pneumoniae collected from various clinical specimens of patients at Saudi Arabia hospitals.

Region City Year of sampling Setting No. isolates Types resistant genes Refs.
Central Riyadh 2016 KKUH  

 

24

 

 

blaSHV

blaCTX-M

blaTEM

blaKPC

blaIMP

Azim et al., 2019
Riyadh 2015 2 hospitals 4 OXA-1

TEM-1-BSBL

AAC(6′)-Ib

Al-Agamy et al.,2019
Riyadh 2011-2012 KAMC  

54

 

NDM-1

OXA-48

Zaman et al., 2018
Riyadh 2014 3 hospitals  

21

 

blaOXA-48

blaNDM

Al-Agamyet al., 2018
Riyadh 2011-2013 KKUH  

5

 

blaNDM

OXA-48

Alotaibi et al.,2017
Southern Abha 2015 2 hospitals 49 VIM

blaIMP

blaOXA-48

blaVIM

Al-Zahrani and Alasiri, 2018
Western Jeddah 2017-2019 KAUH

KAMC

 

 

NDM

OXA-48

Taha et al.,2020
Jeddah Private hospital  

1

 

OXA-48-mediated CAZ-AVI Al Dabbagh et al.,2019
Jeddah 2018-2019 KAMC 1  

blaKPC-2

Halaet al., 1019

KAMC: King Abdulaziz Medical City,KAU H: King Abdulaziz University Hospital, KKUH: King Khalid University Hospital, KFUH: King Fahad University Hospital, KFH: King Fahad Specialist Hospital

Multidrug-resistant Pseudomonas aeruginosa: aeruginosa is important opportunistic pathogen and a frequent cause of hospital-acquired infections mainly in patients with immunocompromised condition, which result in high mortality and morbidity rates in critically ill patients (Kaye and Pogue, 2015). P. aeruginosa is common agents of respiratory system infections, urinary tract infections, dermatitis, pneumonia, cystic fibrosis, bacteremia, surgical infections, soft tissue infections, and a variety of systemic infections (Rabani, and Mardaneh, 2015).

The bacterium, P. aeruginosa is considered a multidrug-resistant if the isolate is resistant to three or more of the following antimicrobial agents: piperacillin, cephalosporins, fluoroquinolones, carbapenems, and aminoglycoside (Defez et al., 2004). These agents are representatives of the primary antibiotic classes used to treat P. aeruginosa infections.

In recent years, a considerable increase in the prevalence of MDR P. aeruginosa has been reported in Saudi Arabia. Furthermore, several studies have identified this prevalence of P. aeruginosa to be the most frequent pathogen in KSA hospitals (Khan et al., 2018). A study conducted at the ICU of King Khalid University Hospital in Riyadh reported a significant increase in resistance of P. aeruginosa. This resistance was reported as 84% to imipenem, 48%to meropenem, 40% to ceftazidime, and 32% to levofloxacin. Ciprofloxacin and piperacillin/ tazobactam showed the same percentage of resistance (28%), followed by 4% to amikacin (Azim et al., 2019).

Cephalosporins proved to be ineffective with significant increase in resistance rate to cefuroxime and ceftazidime during the study period. Consistently, another study conducted at the Hammadi hospital and Habib hospital in Qassim, found that P. aeruginosa isolates were resistant to multiple antimicrobial classes, including cefepime, ceftazidime, amikacin gentamycin, tobramycin, piperacillin/tazobactam, and carbapenem groups (Vijayakumar et al., 2016).

Another study from Madinah, confirmed that P. aeruginosa tends to be resistant to several antibiotics (Saeed et al., 2018). Recent study performed over a 5-month period to determine quinolones susceptibility patterns. The Pseudomonas isolates were collected from different medical departments at a tertiary care hospital in Taif. The 42.4% (39/92) P. aeruginosa isolates were resistant to 1-7 of the tested quinolones. Gemifloxacin resistance rate was the lowest (28.3%) while the resistances to the other six quinolones were ≥ 35% (El-Badawy et al., 2019).

P. aeruginosa showed a gradual increase in carbapenems resistance due to its ability to develop resistance mechanisms to carbapenems and other antibiotics. Many studies informed the increasing rates of resistance to carbapenems among aeruginosa in KSA (Abdalhamid et al., 2016; Bosaeed et al., 2020). A study from Makah, 4803 Gram negative isolates collected from patients in Al-Noor Specialist Hospital. The rate of resistance to carbapenem was among P. aeruginosa (62.4%), K. pneumoniae (38%) and E. coli (5.59%) as reported by Faidah et al. (2017).

Another study from the Western region was conducted by (Alkeshan et al., 2015). Clinical isolates of P. aeruginosa (n=121) were obtained from eight different hospitals in Makkah and Jeddah, P. aeruginosa isolates were highly resistant to meropenem (30.6%), ticarcillin (22.3%), imipenem (19%), piperacillin (17.3%), and (22.3%) to ticarcillin. Another study carried out in tertiary care hospitals of Makkah and Jeddah over a 3-month period to determine the pattern of antimicrobial resistance of P. aeruginosa confirmed these findings(Khan and Faiz, 2016).

The resistance rates in P aeruginosa isolates were 100% for carbapenem and most of them (89%) were non-susceptible to both ciprofloxacin and piperacillin-tazobactam (Bosaeed et al., 2020). During 2011, thirty-four isolates of P. aeruginosa collected from patients hospitalized in a tertiary hospital in Riyadh, were found to be highly resistant to carbapenems (Al-Agamy et al., 2016). Other study by Abdalhamid et al. (2016) evaluated the prevalence of carbapenem-resistant P. aeruginosa (CRPAE) colonization in the ICU patients at admission in two hospitals, found in Dammam and Khobar cities. hey reported the prevalence of CRPAE was 6.5% with resistance rate 45.1%.

Additionally, the major types of acquired b-lactamases that have been identified in P. aeruginosa strains including class A, B, and D β-lactamases, such as VEB-, PER-, GES-, TEM-, SHV- and OXA-types. Carbapenem resistance in P. aeruginosa was attributed to MBLs including IMP, VIM, SPM, GIM, AIM, and DIM enzymes and other enzymes, including KPC, GES, and OXA (Yezli et al., 2015; Sawa et al., 2020). Several studies from Saudi Arabia have been characterized by the molecular basis of β-lactamase and carbapenemase production in P. aeruginosa. Table 1 demonstrates the available data regarding the genetic determinants for ESBL and carbapenemase production by P. aeruginosa.

Table 2. Types of resistant genes carried by P. aeruginosa collected from various clinical specimens of patients at Saudi Arabia hospitals.

Region City Year of sampling Setting No. isolates Resistant genes Refs.
Central Qassim 2015 2 hospitals 11 cepA

qacE

Vijayakumar et al.,2018
Riyadh 2011  1 hospital 34 VEB-1a

VEB-1b

OXA-10

OXA-2

IMP

Al-Agamy et al.,2016
Western Taif 2016-2017  1 hospital 92 qnrD

qnrS,

aac(6´)-Ib-cr

 

El-Badawy et al., 2019

KFUH: King Fahad University Hospital, KFH: King Fahad Specialist Hospital

Multidrug-resistant Acinetobacter baumannii: baumannii is responsible for outbreaks and nosocomial infections such as ventilator-associated pneumonia, burn wound infections, bacteremia and urinary tract infections which occur in patients in intensive care units (Bassetti et al., 2016; Almasaudi, 2018; Ayoub Moubareck and Hammoudihalat, 2020).

A. baumannii is one of the most troublesome bacteria due to its remarkable natural and acquired resistance to nearly all major antibiotics classes including broad-spectrum penicillins, cephalosporins, carbapenems, most aminoglycosides, fluoroquinolones, chloramphenicol, and tetracyclines, which compromises the ability to treat patients who are infected by this pathogen (Karaiskos et al., 2019).

Several reports on the epidemiological studies of nosocomial infections from different regions in Saudi Arabia have focused on the emergence of A. baumannii in healthcare settings and the ICU environment (Kharaba, 2017). At King Abdulaziz Medical City in Riyadh, the most prevalent Gram-negative bacteria in intensive care units was A.  baumannii (17.97%).

Ibrahim (2018) reported that the most secluded pathogens in ICU King Abdullah Hospital was A. baumannii (27.2%) followed by P. aeruginosa (23.8%) and K. pneumoniae (18.6%). In Ministry of National Guard Health Affairs (MNGHA) hospitals in Riyadh, Jeddah, Alhassa and Dammam, the highest MDR- Gram-negative isolates were A. baumannii (58.3%), Klebsiella spp. (20.4%) and E. coli (16.3%) (El-Saed et al., 2020).

baumannii antimicrobial resistance rates in KSA have increased dramatically over the years to many antibiotics including carbapenems. The susceptibilities of A. baumannii to meropenem and imipenem in 2006 ranged between 64-81.2% while the susceptibility in 2012 ranged between 8.3-11% (Al-Obeid et al., 2015). Almaghrabi et al. (2018) recorded 94 clinical A. baumannii isolates collected from Aseer Central Hospital, 69% of these isolates were resistant to all antibiotics except colistin.

A hospital-based, matched case–control study from Makkah, showed the highest resistance rate of A. baumannii was for imipenem (83.3%) followed by gentamicin (72.7%) (Al-Gethamy et al., 2017). A. baumannii isolates were highly resistant to carbapenem (99.13%), followed by P. aeruginosa (62.4%), K. pneumoniae (38%), and E. coli (5.59%) (Faidah et al., 2017). Among 290 Gram-negative isolates collected from ICU at King Abdullah Hospital, Bisha, found that that A. baumannii was the most frequent pathogen with resistance rates from 93.4% to 97.5% for all tested antimicrobial agents except for colistin (Alsultan, 2015, Ibrahim, 2019).

In the Aljouf region, all A. baumannii isolates revealed extended drug-resistance, with 70.6% resistance rate to trimethoprim/ sulfamethoxazole and showed resistance to gentamycin, and carbapenems (Bandy and Almaeen, 2020). A study conducted at a large tertiary care hospital in Taif, confirmed that A. baumannii tends to be resistant to different antibiotics (El-Mahdy et al., 2017, El-Badawy et al., 2019). Also, 66% of A. bumannii isolates were resistant to almost all tested antibiotics and no resistance to colistin was reported (Doi et al., 2015, Halwani et al., 2015).

Resistance to carbapenems is mainly due to carbapenemases and  metallo-β- lactamases (MBLs) production (Leite et al., 2016; Vrancianu et al.,2020). In Saudi Arabia, many studies have shown prevalence of the different β-lactamases, with an emphasis on carbapenemases among A. baumannii isolates and these studies reported that bla OXA-23 gene and a VIM-type metallo-β-lactamase are the most common genes responsible for resistance in A. baumannii (Shah et al.,2019; AlAmri et al., 2020). Table  2 summarized the distribution of β-lactamase and carbapenems resistant genes carried by A. baumannii collected from different regions across KSA.

Table 3. Types of β-lactamase and carbapenems resistant genes carried by A. baumannii collected from various clinical specimens of patients at Saudi Arabia hospitals

Region City Year of sampling Setting No. isolates Resistant genes Refs.
Central Riyadh 2010 1 hospital 27 GES-11

GES-5

OXA-23

Al-Agamy et al., 2017
Riyadh 2006-2014 1 hospital  

503

 

bla -PER-1

bla -TEM

Aly et al., 2016
Riyadh 2011 1 hospital  

62

OXA-23

OXA-40

Alsultan, 2015
Southern Abha 2013-2014 1 hospital 108 OXA-51

OXA-23

OXA-40

OXA-58

Elabd et al., 2015
Western Jeddah 1 hospital  

135

 

blaOXA-23

ISAba1

blaOXA-51

Shah et al.,2019
Taif 2017 1 hospital 32 blaOXA-51 El-Badawy et al.,2019
Eastern Dammam 1 hospital 103 OXA-51

OXA-23

NDM, VIM,

AlAmri et.al.,2020
 

Al-Hassa

1 hospital 5 OXA-23 Alhaddad  et al., 2018
Eastern Region 2014 1 hospital 10 blaOXA-23

ISAba1

blaADC

blaNDM-1

El-Mahdy et al., 2017


CONCLUSION

The high prevalence of multidrug-resistant Gram-negative bacteria in hospitals and community settings has become a serious health concern and a growing threat in Saudi Arabia. The high morbidity and mortality associated with MDR-GN infections resulted in a significant impact on care cost and treatment effectiveness. Therefore, several measures need to be taken to control the spread of these pathogens, including improving infection control programs, early and accurate laboratory detection, judicious use of antimicrobial agents, and enhanced national disease surveillance. Finally, for better detection and control in Saudi Arabia, these procedures need to be combined with molecular typing methods of MDR-GN bacteria.

REFERENCES

Abdalhamid, B., Elhadi, N. and Alabdulqader, N. et al. (2016). Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia. New microbes and new infections, 10, pp.77-83.

Alabdullatif M and Alrehaili J. (2020). Three Years of Evaluation to Determine Reduction of Antibiotic Resistance in Gram-Negative Bacteria by the Saudi National Action Plan. Infect Drug Resist.;13:3657-3667.

Al-Agamy, M.H., Jeannot, K., El-Mahdy, T.S. et al.(2016). Diversity of molecular mechanisms conferring carbapenem resistance to Pseudomonas aeruginosa isolates from Saudi Arabia. Canadian Journal of Infectious Diseases and Medical Microbiology, 32(1), pp.222-232.

Al-Agamy, M.H., Jeannot, K., El-Mahdy, T.S. et al. (2017). First detection of GES-5 carbapenemase producing Acinetobacter baumannii isolate. Microbial Drug Resistance, 23(5), pp.556-562.

Alagna, L., Palomba, E., Mangioni, D. et al. (2020). Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation. International Journal of Molecular Sciences, 21(16), p.5619.

AlAmri, A.M., AlQurayan, A.M., Sebastian, T. et al. (2020). Molecular surveillance of multidrug-resistant Acinetobacter baumannii. Current microbiology, 77(3), pp.335-342.

Al-Gethamy, M.M.,  , H.S., Adetunji, H.A et al. ( 2017). Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia-a matched case–control study. Journal of International Medical Research, 45(3), pp.1181-1189.

Aljindan, R., Bukharie, H., Alomar, A. et al. ( 2015). Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia. Journal of medical microbiology, 64(4), pp.400-406.

Alkeshan, Y.M., Alharbi, S., Alrehaili, F. et al. (2015). Antimicrobial resistance pattern of Pseudomonas aeruginosa in regional tertiary care hospitals of Saudi Arabia. IOSR J. Nurs. Health Sci, 5(2), pp.54-62.

Almaghrabi, M.K., Joseph, M.R., Assiry, M.M. et al. (2018). Multidrug-resistant Acinetobacter baumannii: An emerging health threat in Aseer region, Kingdom of Saudi Arabia. Canadian Journal of Infectious Diseases and Medical Microbiology, 11(4), pp.116-122.

Almasaudi, S.B. (2018). Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi Journal of Biological Sciences, 25(3), pp.586-596.

Al-Obeid, S., Jabri, L., Al-Agamy, M.et al.(2015). Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA). Journal of Chemotherapy, 27(3), pp.156-162.

Alotaibi, F. (2019). Carbapenem-resistant Enterobacteriaceae: an update narrative review from Saudi Arabia. Journal of infection and public health, 12(4), pp.465-471.

Alotaibi, F.E., Bukhari, E.E., Al-Mohizea, M.M. et al. (2017). Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Journal of infection and public health, 10(5), pp.667-673.

Alsultan, A.A. (2015). Clonal diversity of Acinetobacter baumannii mediated by carbapenem resistance in Saudi Arabian hospitals. Int J Curr Microbiol App Sci, 4(5), pp.525-536.

Aly, M.M., Alsoud, N.A., Elrobh, M.S. et al. (2016). High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. European Journal of Clinical Microbiology & Infectious Diseases, 35(11), pp.1759-1766.

Ayoub Moubareck, C. and Hammoudihalat, D. (2020). Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics, 9(3), p.119.

Azim, N. S. A., Al-Harbi, M. A., Al-Zaban, M. I. et al. (2019). Prevalence and Antibiotic Susceptibility Among Gram Negative Bacteria Isolated from Intensive Care Units at a Tertiary Care Hospital in Riyadh, Saudi Arabia. Journal Pure Applied Microbiology, 13(1), pp. 201-208.‏

Bandy, A. and Almaeen, A.H. (2020). Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia. Plos one, 15(6), p.e0233704.

Bassetti, M., Pecori, D. and Peghin, M. (2016). Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options. Italian Journal of Medicine, pp.364-375.

Bosaeed, M., Ahmad, A., Alali, A. (2020). Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center. Infectious Diseases: Research and Treatment, 13, p.11786.

Defez, C., Fabbro-Peray, P., Bouziges, N. et al. (2004). Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. Journal of Hospital Infection, 57(3), pp. 209-216.

Doi, Y., Murray, G.L. and Peleg, A.Y. (2015). Acinetobacter baumannii: evolution of antimicrobial resistance- treatment options. In Seminars in respiratory and critical care medicine. Vol. 36, No. 1, p. 85.

Elabd, F.M., Al-Ayed, M.S., Asaad, A.M. et al. (2015). Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Journal of Infection and Public Health, 8(3), pp.242-247.‏

El-Badawy, M.F., Abdelwahab, S.F., Alghamdi, S.A. et al. (2019). Characterization of phenotypic and genotypic traits of carbapenem- resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia. Infection and drug resistance, 12, p.3113.

El-Mahdy, T. S., Al-Agamy, M. H., Al-Qahtani, A. A. et al. (2017). Detection of bla OXA-23-like and bla NDM-1 in Acinetobacter baumannii from the Eastern Region, Saudi Arabia. Microbial Drug Resistance, 23(1), pp.115-121.

El-Saed, A., Balkhy, H.H., Alshamrani, M.M.et al. (2020). High contribution and impact of resistant gram negative pathogens causing surgical site infections at a multi-hospital healthcare system in Saudi Arabia, 2007–2016. BMC infectious diseases, 20, pp.1-9.

Exner, M., Bhattacharya, S., Christiansen, B. et al. (2017). Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?. GMS hygiene and infection control, 12.

Faidah, H.S., Momenah, A.M., El-Said, H.M.et al. (2017). Trends in the annual incidence of carbapenem resistant among gram negative bacilli in a large teaching hospital in Makah City, Saudi Arabia. Journal of Tuberculosis Research, 5(04), p.229.

Gray, J. W., and Mahida, N. (2016). How do you solve a problem like multidrug-resistant Gram-negative bacteria? Journal of Hospital Infection, 92(1), pp.1-2.‏

Halwani, M.A., Tashkandy, N.A., Aly, M.M. et al.(2015). Incidence of antibiotic resistance bacteria in Jeddah’s Ministry of Health Hospitals, Saudi Arabia. Advances in Microbiology, 5(12), p.780.

Ibrahim, M.E. (2018). High antimicrobial resistant rates among Gram-negative pathogens in intensive care units: A retrospective study at a tertiary care hospital in Southwest Saudi Arabia. Saudi medical journal, 39(10), p.1035.

Ibrahim, M.E. (2019). Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Annals of clinical microbiology and antimicrobials, 18(1), pp.1-12.

Karaiskos, I., Lagou, S., Pontikis, K.et al. (2019). The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how. Frontiers in public health, 7, p.151.

Kaye, K. S., and Pogue, J. M. (2015). Infections caused by resistant gram‐negative bacteria: epidemiology and management. The Journal of Human Pharmacology and Drug Therapy, 35(10), 949-962.‏

Khan, M. A., Al-Motair, K., Alenezi, M. M et al. (2018). Nosocomial Pathogens- A Single Center Study in Saudi Arabia. Journal of Pure and Applied Microbiology, 12(3),pp.1411-6.‏

Khan, M. A., and Faiz, A. (2016). Antimicrobial resistance patterns of Pseudomonas aeruginosa in tertiary care hospitals of Makkah and Jeddah. Annals of Saudi medicine, 36(1), pp.23-28.‏

Kharaba, A. (2017). Prevalence and outcomes of colistin-resistant Acinetobacter infection in Saudi critical care units. Saudi Critical Care Journal, 1(6), p.25.

Leite, G.C., Oliveira, M.S., Perdigão-Neto, L.V. et al. (2016). Antimicrobial combinations against pan-resistant Acinetobacter baumannii isolates with different resistance mechanisms. PloS one, 11(3), p.e0151270.

Nijsingh, N., Munthe, C., Lindblom, A., and Ahren, C. (2020). Screening for multi-drug-resistant Gram-negative bacteria: what is effective and justifiable?. Monash bioethics review, 38(1), pp.72-90.

Rabani, Z. and Mardaneh, J. (2015). Emergence of Multidrug-Resistant Pseudomonas aeruginosa: Detection of Isolates harboring blaCTX gene causing infections in hospital and determination of their susceptibility to antibiotics. Armaghanedanesh, 20(8), pp.689-705.

Saeed, W. M., Ghanem, S., El Shafey, H. M.et al. (2018). In vitro antibiotic resistance patterns of Pseudomonas spp. isolated from clinical samples of a hospital in Madinah, Saudi Arabia. African Journal of Microbiology Research, 12(1), pp. 19-26.‏

Sawa, T., Kooguchi, K. and Moriyama, K. (2020). Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance. Journal of intensive care, 8(1), p.13.

Serra-Burriel, M., Keys, M., Campillo-Artero, C. et al. (2020). Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PloS one, 15(1), p.e0227139.

Shah, M. W., Yasir, M., Farman, M. et al. (2019). Antimicrobial susceptibility and molecular characterization of clinical strains of Acinetobacter baumannii in Western Saudi Arabia. Microbial Drug Resistance, 25(9), pp.1297-1305.

Vijayakumar, R., Al-Aboody, M. S., Meshal, K. A. et al.(2016). Determination of minimum inhibitory concentrations of common biocides to multidrug-resistant gram-negative bacteria. Appl Med Res, 2(3), pp. 56-62.‏

Vijayakumar, R., Sandle, T., Al-Aboody, M. S. et al. (2018). Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii—A first report from the Kingdom of Saudi Arabia. Journal of Infection and Public Health, 11(6), pp.812-816.‏

Vrancianu, C.O., Gheorghe, I., Czobor, I.B. et al. (2020). Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms, 8(6), p.935.

Yezli, S., Shibl, A.M. and Memish, Z.A. (2015). The molecular basis of β-lactamase production in Gram-negative bacteria from Saudi Arabia. Journal of medical microbiology, 64(2), pp.127-136.